83 FR 24810 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 104 (May 30, 2018)

Page Range		24810-24810
FR Document		2018-11559

Federal Register, Volume 83 Issue 104 (Wednesday, May 30, 2018)

[Federal Register Volume 83, Number 104 (Wednesday, May 30, 2018)]
[Notices]
[Page 24810]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-11559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of Microbiology, 
Infectious Diseases and AIDS Initial Review Group Microbiology and 
Infectious Diseases B Subcommittee MID-B.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group Microbiology and Infectious Diseases B 
Subcommittee MID-B.
    Date: June 18-19, 2018.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Ellen S. Buczko, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2676, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 23, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-11559 Filed 5-29-18; 8:45 am]
 BILLING CODE 4140-01-P

24810 Federal Register / Vol. 83, No. 104 / Wednesday, May 30, 2018 / Notices

Dated: May 24, 2018. Microbiology and Infectious Diseases Paperwork Reduction Act (44 U.S.C.
David D. Clary, Research, National Institutes of Health, HHS) Chapter 35). To request a copy of these
Program Analyst, Office of Federal Advisory Dated: May 23, 2018. documents, call the SAMHSA Reports
Committee Policy. Natasha M. Copeland, Clearance Officer on (240) 276–1243.
[FR Doc. 2018–11561 Filed 5–29–18; 8:45 am] Program Analyst, Office of Federal Advisory Project: 2019 National Survey on Drug
BILLING CODE 4140–01–P Committee Policy. Use and Health
[FR Doc. 2018–11559 Filed 5–29–18; 8:45 am]
BILLING CODE 4140–01–P (OMB No. 0930–0110)—Revision
DEPARTMENT OF HEALTH AND The National Survey on Drug Use and
HUMAN SERVICES Health (NSDUH) is a survey of the U.S.
DEPARTMENT OF HEALTH AND civilian, non-institutionalized
National Institutes of Health HUMAN SERVICES population aged 12 years old or older.
National Institute of Allergy and The data are used to determine the
National Institutes of Health
Infectious Diseases; Notice of Closed prevalence of use of tobacco products,
Meeting National Institute on Deafness and alcohol, illicit substances, and illicit use
Other Communication Disorders; of prescription drugs. The results are
Pursuant to section 10(d) of the Amended Notice of Meeting used by SAMHSA, the Office of
Federal Advisory Committee Act, as National Drug Control Policy (ONDCP),
amended, notice is hereby given of a Notice is hereby given of a change in federal government agencies, and other
meeting of Microbiology, Infectious the meeting of the National Institute on organizations and researchers to
Diseases and AIDS Initial Review Group Deafness and Other Communication establish policy, to direct program
Microbiology and Infectious Diseases B Disorders Special Emphasis Panel, June activities, and to better allocate
Subcommittee MID–B. 26, 2018, 11:00 a.m. to June 26, 2018, resources.
2:00 p.m., National Institutes of Health, While NSDUH must be updated
The meeting will be closed to the Neuroscience Center, 6001 Executive
public in accordance with the periodically to reflect changing
Boulevard, Rockville, MD 20852 which substance use and mental health issues
provisions set forth in sections was published in the Federal Register
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., and to continue producing current data,
on May 11, 2018, 83 FR 22091. only the following minor changes are
as amended. The grant applications and This meeting notice is amended to
the discussions could disclose planned for the 2019 NSDUH: (1)
change the time of the meeting from Adding a brief series of questions on
confidential trade secrets or commercial 11:00 a.m.–2:00 p.m. to 10:00 a.m.–1:00
property such as patentable material, medication-assisted treatment (MAT) for
p.m. The meeting is closed to the opioids and alcohol; and, (2) including
and personal information concerning public.
individuals associated with the grant other minor wording changes to
Dated: May 23, 2018. improve the flow of the interview, to
applications, the disclosure of which
would constitute a clearly unwarranted Sylvia L. Neal, increase respondent comprehension, or
invasion of personal privacy. Program Analyst, Office of Federal Advisory to be consistent with text in other
Committee Policy. questions.
Name of Committee: Microbiology, The series of MAT questions seeks to
[FR Doc. 2018–11489 Filed 5–29–18; 8:45 am]
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases BILLING CODE 4140–01–P identify medications prescribed by
B Subcommittee MID–B. health professionals to help reduce or
Date: June 18–19, 2018. stop the use of opioids and alcohol.
Time: 9:00 a.m. to 6:00 p.m. DEPARTMENT OF HEALTH AND Including these questions in NSDUH
Agenda: To review and evaluate grant HUMAN SERVICES will allow SAMHSA to provide the first
applications. known national-level estimates on the
Place: Bethesda North Marriott Hotel & Substance Abuse and Mental Health use of MAT for opioid use disorder and
Conference Center, 5701 Marinelli Road, Services Administration alcohol use disorder.
Bethesda, MD 20852. As with all NSDUH surveys
Contact Person: Ellen S. Buczko, Ph.D., Agency Information Collection
Scientific Review Officer, Scientific Review
conducted since 1999, including those
Activities: Submission for Office of
Program, Division of Extramural Activities, prior to 2002 when the NSDUH was
Management and Budget (OMB)
National Institutes of Health/NIAID, 6700B referred to as the National Household
Review; Comment Request
Rockledge Drive, MSC 7616, Bethesda, MD Survey on Drug Abuse, the sample size
20892–7616, 301–451–2676, ebuczko1@ Periodically, the Substance Abuse and of the survey for 2019 will be sufficient
niaid.nih.gov. Mental Health Services Administration to permit prevalence estimates for each
(Catalogue of Federal Domestic Assistance (SAMHSA) will publish a summary of of the 50 states and the District of
Program Nos. 93.855, Allergy, Immunology, information collection requests under Columbia. The total annual burden
and Transplantation Research; 93.856, OMB review, in compliance with the estimate is shown below in Table 1:

TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2019 NSDUH
Responses
Number of Total number Hours per Total burden
Instrument per
sradovich on DSK3GMQ082PROD with NOTICES

respondents of responses response hours
respondent

Household Screening ........................................................... 137,231 1 137,231 0.083 11,390
Interview ............................................................................... 67,507 1 67,507 1.000 67,507
Screening Verification .......................................................... 4,116 1 4,116 0.067 276
Interview Verification ............................................................ 10,126 1 10,126 0.067 678

VerDate Sep<11>2014 17:04 May 29, 2018 Jkt 244001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\30MYN1.SGM 30MYN1

Document Created: 2018-05-30 01:01:27
Document Modified: 2018-05-30 01:01:27

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 18-19, 2018.
FR Citation		83 FR 24810

83 FR 24810 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 104 (May 30, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health